Have you noticed that your eyelashes arent as full and long as they once were? This is a common issue: The average length, thickness, and darkness of eyelashes decrease as women age. Luckily, this problem can be treated by using Latisse.
What is Latisse?
Latisse is a prescription treatment for fuller, longer, and darker lashes. It is applied once daily at nighttime to the lash line on the upper eyelid. It is the only FDA approved solution for growing lashes.
Latisse Results
Latisse solution works gradually so you should not expect immediate results over night. After four weeks, you may begin to see longer lashes. After eight weeks, you may begin to see fuller and darker lashes, and at week sixteen, you will see your full results. Latisse is not a permanent fix! If you stop using Latisse, your eyelashes are expected to return to their original appearance over several weeks to months.
Safety Information
As with any prescription treatment, you should be aware of the common side effects before use. Latisse can cause eye itching or redness. Less common, it can cause some skin darkening, eye irritation, dryness, or redness of the eyelids. Latisse use may cause increased brown pigmentation of colored eyes, which is likely permanent. Latisse solution should not be applied inside the eye or to the lower eyelid.
How To Use
Latisse should be used once daily after your cleanse your face before bed. All makeup and contact lenses should be removed before use. Remove a fresh applicator from the package and hold it horizontal while applying a drop of Latisse solution to the tip. Immediately draw the applicator along the skin at the base of the upper eyelashes. Blot away any excess liquid and throw away the applicator. Make sure you use a fresh applicator for each application to avoid any contamination from one eyelid to the other!
Latisse is available for purchase in our Ashburn office. For more information, check out the Latisse page on our website.
Treatment for Inadequate Eyelashes
Schedule a ConsultationPosted August 22, 2014 in News